Cullinan Therapeutics, Inc. ($CGEM)
AHMED NADIM โ Director
Shares
13,515
Price
$14.47
Total Value
$195,562.05
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.80
Revenue:Est: $5.56M
Mar 10, 2026
EPS:-0.77 (est: -0.81)-4.9%
Revenue:Est: $5.00M
Transaction Details
| Insider | AHMED NADIM |
|---|---|
| Title | Director |
| Transaction Date | Feb 24, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 25, 2026 |
| Shares Sold | 13,515 |
| Price per Share | $14.47 |
| Total Value | $195,562.05 |
| Shares Owned After | 390,803 |
| Derivative | No |
| Accession Number | 0001193125-26-072001 |
| Document | View SEC Filing |